drugset / Trial / NCT00891384
Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple Myeloma
Phase 3
Completed
194 enrolled
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
RandomizedParallel-groupSingle-blindTreatment
Summary
This trial is a randomised, parallel-group, multicenter phase III study for maintenance therapy with lenalidomide in patients with multiple myeloma who were treated with high-dose therapy and autologous stem cell transplantation as first line therapy.
Timeline
- Start
- 2009-04-01
- Primary completion
- 2017-06-22
- Completion
- 2017-06-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenalidomide | Other / unclassified | 5 mg | — |
| Subject | Lenalidomide | Other / unclassified | 25 mg | — |